title: Venetoclax: a new weapon to treat high-risk CLL.
authors.affiliation: Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, 6500 Bellinzona, Switzerland. Electronic address: davide.rossi@eoc.ch.
authors.forename: Davide
authors.initials: D
authors.lastname: Rossi
mesh_terms: D019086:Bridged Bicyclo Compounds, Heterocyclic; D006801:Humans; D013449:Sulfonamides; D054041:Weapons
chemical_list: D019086:Bridged Bicyclo Compounds, Heterocyclic; D013449:Sulfonamides; C579720:venetoclax